The proposed acquisition by Exponent Private Equity LLP of Xeinadin Group Limited has been cleared by the Competition Consumer Protection Commission.
|Notification date||Decision date|
|Monday January 24, 2022||Thursday, April 28, 2022|
|Parties Involved||Business activities|
|Exponent Private Equity LLP||
Exponent is a limited liability partnership incorporated in England and Wales that makes private equity investments in businesses located in the United Kingdom, Ireland and across Europe. Exponent’s investments involve a range of different industry sectors, including healthcare, food, transportation, advertising, and finance.
|Xeinadin Group Limited||
Xeinadin is a financially consolidated group of accounting firms spread across the UK and Ireland that is ultimately owned by individuals who work in its member offices. Xeinadin offers accounting and bookkeeping, payroll, tax, audit and business consulting (including corporate finance and restructuring) services to entrepreneurs, small or medium enterprises with less than 250 full-time employees and not-for-profit organisations
|Economic sector||Media merger|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Friday, February 4, 2022|
|Current status: Completed|
|Cleared (Phase 1)|
|Authorised Officer Assigned||Contact Details|
Media enquiries: firstname.lastname@example.org